Biomarkers That Strengthen Medical Necessity Documentation Beyond HbA1c, specific biomarkers indicate cardiometabolic dysfunction and support insurance approval arguments
Furthermore, some GLP-1 RAs are reported to reduce the risk of 3-point major adverse cardiovascular events (MACE) 6, 7 , and a meta-analysis of four large-scale clinical studies that assessed GLP-1 RAs concluded that these agents can reduce the risk of cardiovascular events and all-cause mortality 8
doi: 10.1080/19490976.2020.1831339 160 Vargas-RoblesH.Castro-OchoaK
Cette approche est particulirement pertinente lorsque la sensation de gonflement saccompagne de jambes lourdes ou dune impression de rtention diffuse
A major concern people have when starting GLP-1 medications is that most of the weight lost will be muscle mass
For example, obstructive sleep apnea (OSA) risk has been implicated as an independent risk factor for difficult-to-control asthma, demonstrating an interplay between these two conditions [42]
